担忧mRNA新冠疫苗饱和赛诺菲告退，国内厂商未放弃

尽管放弃了mRNA疫苗研发，但赛诺菲与英国制药商葛兰素史克（GSK）基于重组蛋白疫苗的研发合作将继续推进，该疫苗目前正在进行大规模试验。

Related Keywords

Germany ,Australia ,Philippines ,United States ,United Kingdom ,China ,Geneva ,Genè ,Switzerland ,Pennsylvania ,Canada ,New Crown ,Northern Territory ,France ,Sri Lanka ,Brad Long ,Research Market ,Pennsylvania University Medicine ,Research Professor ,Sinopharmb Health ,Novo Philippines ,Novo Philippines Tuesday ,Hui Switzerland ,Guo China New Crown ,China Genesis ,Market The ,Asia Country ,China Market ,New Yao ,Hui Switzerland Monday ,Lasker Award ,Medical Research ,Nobel Prize ,赛诺菲 ,Mrna疫苗 ,新冠 ,流感疫苗 ,